Group One Trading’s Profound Medical PROF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-150
Closed -$747 8944
2025
Q3
$747 Buy
+150
New +$766 ﹤0.01% 8103
2024
Q4
Sell
-1
Closed -$8 7818
2024
Q3
$8 Hold
1
﹤0.01% 6533
2024
Q2
$8 Buy
+1
New +$8 ﹤0.01% 6599
2023
Q4
Sell
-99
Closed -$940 8038
2023
Q3
$1.01K Buy
+99
New +$1.03K ﹤0.01% 7215
2023
Q1
Sell
-174
Closed -$2.01K 7795
2022
Q4
$1.9K Buy
174
+100
+135% +$545 ﹤0.01% 6673
2022
Q3
$0 Hold
74
﹤0.01% 8081
2022
Q2
$1K Hold
74
﹤0.01% 7605
2022
Q1
$1K Hold
74
﹤0.01% 7858
2021
Q4
$1K Hold
74
﹤0.01% 8012
2021
Q3
$1K Buy
+74
New +$1.13K ﹤0.01% 8036

Other funds holding PROF

Group One Trading's PROF Position: Q4 2025 in Review

Group One Trading sold out of Profound Medical (PROF) in Q4 2025, closing a stake of 150 shares — an estimated $747 sold.

Group One Trading first reported a position in PROF in Q3 2021 and held it in 10 quarters. The position peaked at $1.9K in Q4 2022. 63 funds tracked by Wall St. Rank hold PROF as of Q4 2025.

  • Group One Trading reported no remaining Profound Medical position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 150 Profound Medical shares in Q4 2025, an estimated $747.
  • Group One Trading first reported a position in Profound Medical in Q3 2021 and held it in 10 quarters.
  • Group One Trading's Profound Medical position peaked at $1.9K in Q4 2022.
  • 63 funds tracked by Wall St. Rank held Profound Medical as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.